Advertisement
Screener

Ghost Tree Capital, LLC Historic Quarter Change: Foreign Stocks, Sold Out

Ghost Tree Capital, LLC historic quarter change: Foreign Stocks, Sold out

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 6 positions, added to 1, reduced 5 and sold out of 9.

  • Q2 2024: Stock GPCR; Country of operation United States; Class SPONSORED ADS; Shares before 75,000.
  • Q1 2024: Stock ARGX; Country of operation —; Class SPONSORED ADR; Shares before 15,000.
  • Q1 2024: Stock VRNA; Country of operation —; Class SPONSORED ADS; Shares before 30,000.
  • Q2 2016: Stock ADAPY; Country of operation United Kingdom; Class SPONDS ADR; Shares before 50,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2024GPCR
STRUCTURE THERAPEUTICS INC
United StatesSPONSORED ADS75,0000-75,000$3,214,500$0-$3,214,5002024-08-14
Q1 2024ARGX
ARGENX SE
SPONSORED ADR15,0000-15,000$5,706,450$0-$5,706,4502024-05-15
Q1 2024VRNA
VERONA PHARMA PLC
SPONSORED ADS30,0000-30,000$596,400$0-$596,4002024-05-15
Q2 2016ADAPY
ADAPTIMMUNE THERAPEUTICS PLC
United KingdomSPONDS ADR50,0000-50,000$407,000$0-$407,0002016-08-12
Q4 2015CLLS
CELLECTIS - ADR
SPONSORED ADS75,0000-75,000$1,977,000$0-$1,977,0002016-02-17
Q3 2015ADAPY
ADAPTIMMUNE THERAPEUTICS PLC
United KingdomSPONDS ADR76,8500-76,850$1,409,000$0-$1,409,0002015-11-16
Q1 2015SNN
SMITH & NEPHEW PLC
SPDN ADR NEW30,0000-30,000$1,102,000$0-$1,102,0002015-05-15
Q3 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR100,0000-100,000$5,242,000$0-$5,242,0002014-11-14
Q2 2014SGMOQ
SANGAMO BIOSCIENCES INC
United StatesCOM86,6060-86,606$1,566,000$0-$1,566,0002014-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet